Indeed, Random Forest Analysis determined that the expression of both NOR-1 and PPARδ were specifically decreased in CD14+ cells (mainly monocytes) from patients with metabolic syndrome, identifying these patients with high specificity and sensitivity [133]. Here, NR4A3 is linked to metabolic syndrome.